Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management

Description

The goal of this clinical trial is to learn whether IBD patients have better disease outcomes and feel more empowered to manage their condition if they have access to text messaging with their clinical team and if their symptoms are more regularly monitored through text-based surveys. Researchers will compare participants who have access to text-based monitoring, communication and education to participants who have access to text-based education alone. Researchers will also examine if different social and other non-medical factors impact IBD symptoms and quality of life. All participants will: * complete 5 brief on-line surveys over 12 months about their IBD and social risk factors, * receive IBD education content by text message up to 2 times a week. Some participants will also: * receive additional surveys by text to monitor their IBD progression, * have the opportunity to directly text message their IBD medical team.

Conditions

Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Colitis

Study Overview

Study Details

Study overview

The goal of this clinical trial is to learn whether IBD patients have better disease outcomes and feel more empowered to manage their condition if they have access to text messaging with their clinical team and if their symptoms are more regularly monitored through text-based surveys. Researchers will compare participants who have access to text-based monitoring, communication and education to participants who have access to text-based education alone. Researchers will also examine if different social and other non-medical factors impact IBD symptoms and quality of life. All participants will: * complete 5 brief on-line surveys over 12 months about their IBD and social risk factors, * receive IBD education content by text message up to 2 times a week. Some participants will also: * receive additional surveys by text to monitor their IBD progression, * have the opportunity to directly text message their IBD medical team.

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management

Condition
Inflammatory Bowel Diseases
Intervention / Treatment

-

Contacts and Locations

San Diego

University of California San Diego, San Diego, California, United States, 92093

San Francisco

University of California San Francisco Benioff Children's Hospital, San Francisco, California, United States, 94158

Atlanta

Morehouse School of Medicine, Atlanta, Georgia, United States, 30310

Boston

Boston Medical Center, Boston, Massachusetts, United States, 02118

Lake Success

NYU Langone Health Lake Success, Lake Success, New York, United States, 11042

Chapel Hill

UNC-Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States, 27599

Charlotte

Atrium Health Levine Children's, Charlotte, North Carolina, United States, 28203

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 13+ years old with IBD (Crohn's disease, ulcerative colitis, indeterminant colitis).
  • * Followed at a participating site with an office visit (in-person or virtual) within the preceding 12 months.
  • * Have access to a mobile phone and willing and able to receive and respond to text messages.
  • * Willing to answer questions on electronic surveys.
  • * Have the ability to read text messages and answer surveys in English or Spanish.
  • * IBD patients s/p surgery with a current pouch or ostomy.
  • * Unable to provide informed consent and child assent for minors.

Ages Eligible for Study

13 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of North Carolina, Chapel Hill,

Michael D Kappelman, MD, MPH, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

2028-09